Circular RNAs in diabetes mellitus and its complications

• Published in: Frontiers in endocrinology (Lausanne) Vol. 13; p. 885650
• Main Authors: Fan, Wenqi, Pang, Haipeng, Xie, Zhiguo, Huang, Gan, Zhou, Zhiguang
• Format: Journal Article
• Language: English
• Published: Frontiers Media S.A 01.08.2022
• Subjects: CircRNAs; diabetes-associated complications; Endocrinology; gestational diabetes mellitus; type 1 diabetes mellitus; type 2 diabetes mellitus
• ISSN: 1664-2392; 1664-2392
• DOI: 10.3389/fendo.2022.885650

Diabetes mellitus (DM) is an endocrine disorder characterized by a relative or absolute lack of insulin due to the dysfunction or destruction of β-cells. DM is one of the fastest growing challenges to global health in the 21 st century and places a tremendous burden on affected individuals and their families and countries. Although insulin and antidiabetic drugs have been used to treat DM, a radical cure for the disease is unavailable. The pathogenesis of DM remains unclear. Emerging roles of circular RNAs (circRNAs) in DM have become a subject of global research. CircRNAs have been verified to participate in the onset and progression of DM, implying their potential roles as novel biomarkers and treatment tools. In the present review, we briefly introduce the characteristics of circRNAs. Next, we focus on specific roles of circRNAs in type 1 diabetes mellitus, type 2 diabetes mellitus, gestational diabetes mellitus and diabetes-associated complications.